1607TiP - J-FORCE study: A randomized, double-blind, placebo-controlled phase III study evaluating olanzapine (5 mg) combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based, highly emetogenic chemotherapy
| Autor: | Hashimoto, H., Iwasa, S., Abe, M., Yanai, T., Zenda, S., Yamaguchi, T., Kaba, H., Fukuda, H., Terakado, H., Ohe, Y. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v564-v565 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|